RxDoctor Payments DataLook up a doctor →

Joseph Lovato, DO

Family Medicine · Northglenn, CONPI 1558332247

Payments from drug & device makers

$20,989in general payments, 2019–2025

Across 892 payments — averaging $23.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sekisui Diagnostics LLC$6K
  • AbbVie$3K
  • AstraZeneca$2K
  • GSK$1K
  • Boehringer Ingelheim$1K
  • Novo Nordisk$1K
  • plus $7K from 51 others

What the payments were for

  • Food & beverage$15,453100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sekisui Diagnostics LLC2$5,525
AbbVie(2 entities)203$3,131
AstraZeneca88$1,941
GSK68$1,151
Boehringer Ingelheim61$1,075
Novo Nordisk70$1,031
Lilly USA, LLC49$758
Amgen54$754
Johnson & Johnson37$716
Pfizer40$569
Abbott25$506
Novartis19$384
Astellas Pharma US Inc21$319
Bayer10$279
Teva Pharmaceuticals USA, Inc.12$220
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)9$218
Regeneron Healthcare Solutions, Inc.5$189
Merck14$186
Esperion Therapeutics, Inc.10$186
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$151
Exact Sciences5$129
Amarin Pharma, Inc.6$116
Aroa Biosurgery Incorporated1$99
Idorsia Pharmaceuticals US Inc6$87
Biohaven Pharmaceuticals, Inc.4$72
Inspire Medical Systems, Inc.1$72
Otsuka America Pharmaceutical, Inc.3$68
Sanofi-aventis U.S. LLC4$64
Takeda Pharmaceuticals U.S.A., Inc.3$64
Shire North American Group Inc4$63
Kowa Pharmaceuticals America, Inc.4$63
Sumitomo Pharma America, Inc.3$62
Eisai Inc.4$61
Sunovion Pharmaceuticals Inc.3$59
Biohaven Pharmaceutical Holding Company Ltd.2$58
E.r. Squibb & Sons, L.L.C.2$49
Axsome Therapeutics, Inc.2$49
Jazz Pharmaceuticals Inc.3$42
Nestle Healthcare Nutrition Inc.2$36
Heartflow, Inc.2$35
IBSA Pharma Inc.2$34
Daiichi Sankyo Inc.2$33
Aimmune Therapeutics, Inc.2$32
Endo Pharmaceuticals Inc.2$27
Phathom Pharmaceuticals, Inc.1$26
Collegium Pharmaceutical, Inc.1$22
Dermira, Inc.1$22
Mannkind Corporation1$18
Xeris Pharmaceuticals, Inc.1$17
Circassia Inc.1$17
Sanofi Pasteur Inc.1$16
Neos Therapeutics, LP1$16
Scilex Pharmaceuticals Inc.1$15
Dynavax Technologies Corporation1$14
Medtronic1$14
Biodelivery Sciences International, Inc.1$14
Avanir Pharmaceuticals, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,989 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$27,538
Medicare patients
138
Services billed
6,215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$46,582
MounjaroTirzepatide29$37,878
EliquisApixaban31$36,145
JanuviaSitagliptin Phosphate17$21,800
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$15,433
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$8,593
Fluticasone-SalmeterolFluticasone Propion/Salmeterol25$3,028
Focalin XrDexmethylphenidate Hcl11$2,545
Diclofenac Sodium61$2,232
Levothyroxine Sodium215$1,932
Gabapentin68$1,837
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen54$1,746
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen47$1,587
Celecoxib40$1,561
HumalogInsulin Lispro22$1,539

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,031$46,58239 claims
Lilly USA, LLCMounjaro, Humalog$758$39,41751 claims
PfizerEliquis$569$36,14531 claims
MerckJanuvia$186$21,80017 claims
GSKTrelegy Ellipta$1,151$15,43318 claims
Scilex Pharmaceuticals Inc.Colchicine$15$77221 claims
Teva Pharmaceuticals USA, Inc.Loxapine$220$69213 claims
AbbVieSynthroid$3,131$59615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Northglenn

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →